The Global X Conscious Companies ETF (KRMA) is designed to provide investors an opportunity to invest in well-managed companies that achieve financial performance in a sustainable and responsible manner and exhibit positive Environmental, Social and Corporate Governance (ESG) characteristics.
The Global X Conscious Companies ETF (KRMA) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Concinnity Conscious Companies Index.
As the first ETF to utilize the Multi-stakeholder Operating System (MsOS), KRMA offers exposure to companies achieving positive outcomes for 5 key stakeholders: Customers, Suppliers, Stock & Debt Holders, Local Communities, and notably, Employees.
Through the Concinnity Conscious Companies Index, KRMA employs proactive (positive) screens in a proprietary, 3-step process that monitors for consistent achievement, establishing a very high bar for inclusion.
KRMA applies a wide range of sources that focus on measuring positive outcomes, including fundamental financial ratios to assess for operational efficiency and other long-term value creation indicators.
| Ticker | KRMA |
| Inception Date | 7/11/16 |
| CUSIP | 37954Y 731 |
| ISIN | US37954Y7316 |
| Bloomberg Index Ticker | KRMATR |
| Primary Exchange | Nasdaq |
| Net Assets | $217,269,929 |
| NAV | $19.93 |
| Shares Outstanding | 10,900,000 |
| Total Expense Ratio | 0.43% |
| 30-Day SEC Yield | 1.97% |
| Distribution Frequency | Semi-Annually |
| NAV | Price | ||||
|---|---|---|---|---|---|
| Net Asset Value | $19.93 | Closing Price | $19.90 | ||
| Daily Change | $0.37 | 1.89% | Daily Change | $0.36 | 1.84% |
Cumulative %Data as of month end (3/31/20) |
Fund NAV | Closing Price | Index |
|---|---|---|---|
| 1 Month | -14.33% | -14.63% | -14.35% |
| 3 Months | -22.43% | -22.72% | -22.40% |
| 6 Months | -16.46% | -16.85% | -16.31% |
| Since Inception | 28.11% | 27.96% | 30.35% |
Avg Annualized %Data as of month end (3/31/20) |
Fund NAV | Closing Price | Index |
|---|---|---|---|
| 1 Year | -11.86% | -11.91% | -11.52% |
| 3 Years | 4.31% | 4.25% | 4.83% |
| Since Inception | 6.88% | 6.85% | 7.38% |
Avg Annualized %Data as of quarter end (3/31/20) |
Fund NAV | Closing Price | Index |
|---|---|---|---|
| 1 Year | -11.86% | -11.91% | -11.52% |
| 3 Years | 4.31% | 4.25% | 4.83% |
| Since Inception | 6.88% | 6.85% | 7.38% |
Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized Return is the average return gained or lost by an investment each year over a given time period.
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted.
| Return on Equity | 17.40% | |
| Average Market Cap | $96,696.00 M | |
| 2019 | 2020 | |
| Price-to-earnings | 15.56 | 16.56 |
| Price-to-book value | 3.04 | 2.73 |
Source: AltaVista Research, LLC
| Versus | Beta |
|---|---|
| S&P 500 | 1.03 |
| MSCI EAFE | 0.97 |
| MSCI Emg. Mkts | 0.72 |
| Standard Deviation | 15.90% |
Source: AltaVista Research, LLC
| Net Assets % | Name | Market Price ($) | Shares Held | Market Value ($) |
|---|---|---|---|---|
| 1.12 | REGENERON PHARMACEUTICALS | 512.96 | 4,754 | 2,438,611.84 |
| 0.96 | NEWMONT CORP | 57.31 | 36,573 | 2,095,998.63 |
| 0.87 | CLOROX COMPANY | 184.21 | 10,232 | 1,884,836.72 |
| 0.87 | BIOGEN INC | 321.05 | 5,858 | 1,880,710.90 |
| 0.82 | AMAZON.COM INC | 2,042.76 | 871 | 1,779,243.96 |
| 0.82 | VERTEX PHARM | 246.61 | 7,191 | 1,773,372.51 |
| 0.79 | GENERAL MILLS INC | 57.40 | 30,084 | 1,726,821.60 |
| 0.79 | NVIDIA CORP | 262.95 | 6,508 | 1,711,278.60 |
| 0.79 | ELI LILLY & CO | 145.73 | 11,712 | 1,706,789.76 |
| 0.79 | PROGRESSIVE CORP | 80.39 | 21,220 | 1,705,875.80 |
| Holdings are subject to change. Cash, where shown, includes other assets and liabilities, such as payables and receivables. | ||||
Investing involves risk, including the possible loss of principal. KRMA may underperform other similar funds that do not consider conscious company guidelines when making investment decisions.
Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Global X NAVs are calculated using prices as of 4:00 PM Eastern Time. The closing price is the Mid-Point between the Bid and Ask price as of the close of exchange. Closing price returns do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.
Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.
Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Concinnity, nor does Concinnity make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Concinnity.
888-493-8631
Leave us a note